In a rapidly evolving tobacco marketplace, research and evidence-based advocacy in action can help avert public health crises and achieve landmark progress in tobacco control.1 Research in action here ...

In a major step forward for HIV prevention, the FDA has approved lenacapavir—branded as Yeztugo the first HIV prevention shot that only needs to be taken twice a year.

The Food and Drug Administration approved the first injectable HIV prevention medication, which could be a massive step forward in ending the long-term epidemic.

Posted: June 19, 2025 | Last updated: June 19, 2025 It's the world's first twice-yearly shot and was shown in trials to be 96% effective at preventing HIV. Advocates call it a gamechanger.

The U.S. Food and Drug Administration (FDA) approved a new, twice-yearly shot — the first and only of its kind — to prevent HIV, the creator of the drug, Gilead Sciences, announced on Wednesday.

Environment Animals Wildlife Fish FDA approves lab-grown salmon Wildtype's 'cultivated' fish is the first of its kind to get the green light. By Andrew Paul Published Jun 9, 2025 11:10 AM EDT ...

The FDA has approved Alcon’s acoltremon (Tryptyr) for signs and symptoms of dry eye disease. This is the first approval for an agonist of TRPM8, an ion channel that detects cold and menthol and ...

The FDA has approved a new, twice-yearly PrEP injection from pharmaceutical giant Gilead. The drug is lenacapavir. The twice-yearly formulation has the brand name Yeztugo.

Local FDA approves first twice-a-year HIV prevention shot with near-perfect protection By WSB Radio News Staff June 19, 2025 at 10:14 am EDT (erika8213 - stock.adobe.com) ...

The FDA has approved clesrovimab-cfor (Enflonsia), Merck’s long-acting monoclonal antibody, for the prevention of respiratory syncytial virus (RSV) lower respiratory tract disease in neonates ...

Yeztugo (lenacapavir) is now the first and only HIV prevention option approved by the U.S. FDA that offers protection for six months. Yeztugo received FDA approval under Priority Review.